Cell therapies, which have made waves in the treatment of blood cancer, are showing potential for solid tumors.
CorriXR Therapeutics, an oncology-focused biotherapeutics company pioneering a ground-breaking gene editing platform technology, InhaTarget Therapeutics, a company dedicated to the early development ...
The Food and Drug Administration granted accelerated approval on Wednesday for a new drug developed by researchers at the ...
Lung Cancer Awareness Month highlights the importance of staying informed about advancements, screening, and preventive ...
Future SCLC treatment may involve combining T-cell engagers with immune checkpoint inhibitors to enhance patient outcomes.
For decades, lung cancer has been associated with stigma, anxiety, and loss. Advances in screening, therapeutics, and ...
PUSH FOR BETTER LUNG CARE Led by the Lung Health Alliance of the Philippines (LungHAP), medical experts, patient groups and ...
2don MSNOpinion
He's a leading expert in nonsmoker lung cancer. After he got the disease, insurance denied his treatment
OPINION: Stanford Dr. Bryant Lin is both a patient and an advocate in yet another vexing health care problem: insurance ...
A 75-year-old man with non-small cell lung cancer shows radiologic enlargement after neoadjuvant therapy; however, ...
Reports show lung cancer mortality in Ohio is decreasing, but the disease remains the leading cause of cancer deaths in ...
As with many types of cancer, early detection of lung cancer is critical for improving health outcomes, and advances in robotic technology have become essential tools in early screening and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback